Karin Shanahan
Executive Vice President, Global Product Development & Supply Bristol Myers Squibb
ABOUT THE WINNER
Karin Shanahan’s career spans over 25 years in the life sciences industry. She began her professional journey at Bristol Myers Squibb and moved through various roles of increased accountability in supply chain, quality, and manufacturing. She has led operations in multiple countries, significantly improving site performance and operational excellence.
Currently serving as EVP, Global Product Development & Supply, Karin is a member of the BMS executive committee and is responsible for product development, quality, supply chain, manufacturing operations, and global technical services.
Her passion for purpose fuels her leadership, because the delivery of each medicine is more than a milestone. It’s a promise of hope, time, and possibility for patients and their families. Outside of her professional life, she enjoys spending quality time with her husband and three daughters.
Congratulations, Karin Shanahan!
Case Study Highlights
Karin Shanahan is guiding Bristol Myers Squibb through a bold supply chain transformation, centered on digital-first strategies and unified visibility. A major achievement is the end-to-end integrated supply planning system that improves speed, insights, and enterprise decision-making.
Digital systems enable seamless collaboration across commercial, finance, and operations. “What-if” analysis, data democratization, and scenario planning tools help the company respond faster to change. These capabilities are foundational to delivering more medicines to more patients, faster.
Karin’s leadership introduced the new GPS operating model, enhancing global coordination and operational excellence. This has enabled synchronized planning, optimized site performance, and patient-centric innovation across the network.
She leads a 10,000-person global organization grounded in purpose. With cross-functional teamwork and shared truth in data, BMS builds a competitive, sustainable supply chain. Karin credits the transformation to her team’s collaboration and commitment to patient impact.
